Key facts
- Notable investors include Hubei Yangtze River Industrial Investment Group, Hubei Changjiang Capital Investment Fund Management, Yichen Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Fulton Holdings (China)
- ·The full record, as it builds
Funding rounds
No funding rounds for Fulton Holdings (China) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fulton Holdings (China)
Developer of high purity reagent focusing on separation and purification, chiral drug molecule synthesis and trace detection and analysis technology. The company's product can be widely used in medicine, scientific research and analytical testing and other fields, providing clients with high quality local reagent.
- Sector
- Healthcare
- HQ
- Wuhan, China
- Founded
- 2018
- Website
- ftsci.com.cn/
- Ownership
- Privately Held (backing)
Fulton Holdings (China) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fulton Holdings (China) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fulton Holdings (China) in its N-PORT filings yet. We sweep new filings monthly.